Chevron is poised to gain from rising crude prices, but the energy sector remains volatile. Can this "super major" overcome the industry's uncertainties? Read More

With FDA Chief Scott Gottlieb's departure, we're already seeing big price swings in stocks that may be affected by a change in FDA policy towards tobacco and health care companies. Read More

As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More

Many traders analyze stock charts to guide them in their trading decisions. We take a basic look at how understanding resistance and support levels can help a trader make money. Read More

Health services giant Johnson & Johnson has been a reliable growth-and-income stock for years, but can it overcome the scandal about its allegedly carcinogenic talcum powder? Read More

In working for billionaires during his career, the author learned investment truisms that he shares with you here. Read More

General Motors has proven itself a survivor, emerging from the federal government bailout in competitive shape. But disruptive technology and economic storm clouds now threaten this Detroit icon. Read More

Given the stock market’s erratic behavior, a lot of money can be made in these three beaten-down stocks that could move strongly in the weeks to come. Read More

Cash-rich tech titans such as Microsoft have become growth-and-income plays. But as headwinds mount for the tech sector, how safe is the firm's dividend? Read More

For this week’s Big Interview, we pose questions to Dr. Stephen Leeb, renowned investment analyst and best-selling author. Read More